Here are relevant reports on : companion-diagnostics-market
-
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Global Forecast to 2028
The global microbiome diagnostics market, valued at US$126 million in 2022, stood at US$146 million in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$300 million by the end of the period. Market growth is driven by the rising incidence of chronic diseases, collaborative efforts between microbiome industry and academic institutes, and growing demand of personalized medicine.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
AI in Telecommunication Market by Technology, Application (Network Optimization, Network Security, Self-diagnostics, Customer Analytics, and Virtual Assistance), Component (Solutions and Services), Deployment Mode, and Region - Global Forecast to 2022
The increasing adoption of Artificial Intelligence (AI) for various applications in the telecommunication industry and utilization of AI-enabled smartphones are expected to be driving the growth of the AI in telecommunication market. MarketsandMarkets expects the global AI in telecommunication market to grow from USD 235.7 Million in 2016 to USD 2,497.8 Million by 2022, at a Compound Annual Growth Rate (CAGR) of 46.8% during the forecast period. The base year considered for the study is 2016 and the forecast period is 2017–2022. The AI in telecommunication market report encompasses the competitive landscape and company profiles of the key vendors based on their product offerings and business strategies. The major AI in telecommunication vendors include IBM (US), Microsoft (US), Intel (US), Google (US), AT&T (US), Cisco Systems (US), Nuance Communications (US), Sentient Technologies (US), H2O.ai (US), Infosys (India), Salesforce (US), and NVIDIA (US).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. Some of the the top players in this market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Glycomics Market / Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
The global glycomics market in terms of revenue was estimated to be worth $1.8 Billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 15.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Edge Computing in Healthcare Market by Component (Hardware, Software, Services), Application (Diagnostics, Robotic Surgery, Telehealth, RPM, and Ambulances), End User (Hospitals, Clinics, Ambulatory Care Center), & Region - Global Forecast to 2028
The global edge computing in healthcare market, valued at US$4.1 billion in 2022, stood at US$4.9 billion in 2023 and is projected to advance at a resilient CAGR of 26.1% from 2023 to 2028, culminating in a forecasted valuation of US$12.9 billion by the end of the period. Edge computing is gaining popularity across industries as there is a rise in the number of devices, which has increased the demand for high-bandwidth applications with the growing use of internet services.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Poultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis, Encephalomyelitis, Infectious Bronchitis), Service (Virology, Bacteriology, Parasitology) - Global Forecast to 2022
The global poultry diagnostics market is projected to reach USD 495.3 Million by 2022 from USD 300.6 Million in 2017, growing at a CAGR of 10.5%. Significant increase in the avian diseases outbreak and rising incidence of zoonotic diseases, rising consumer focus on food safety along with the increasing animal health awareness, and increasing trade in terms of export within the poultry industry are the major drivers for the growth of the poultry diagnostics market.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Laser Capture Microdissection Market by Product (Instruments, Consumables, Software, Services), System Type (Ultraviolet, Infrared, Immunofluorescence), Application (R&D (Molecular Biology, Cell Biology, Forensics), Diagnostics) & Region - Global Forecast to 2029
The global laser capture microdissection market, valued at US$176 million in 2023, stood at US$184 million in 2024 and is projected to advance at a resilient CAGR of 10.6% from 2024 to 2029, culminating in a forecasted valuation of US$306 million by the end of the period. The growth of this market is majorly driven by the rising pace of R&D and growing expenditure. On the other hand, requirement of high degree of technical expertise is a major factor restraining market growth to a certain extent.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Metabolism Assays Market Size, Share & Trends by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabetes, Obesity), Research), End User (Hospitals, Diagnostic Laboratories), & Region - Global Forecast to 2028
The global metabolism assays market, valued at US$1.3B in 2022, is forecasted to grow at a 7.8% CAGR, reaching US$1.4B by 2023 and US$2.1B by 2028. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Laboratory Proficiency Testing Market by Industry (Clinical Diagnostics, Microbiology, Pharmaceutical, Food & Animal Feed, Water, Opioid), Technology (PCR, Cell Culture), and Region; Unmet Needs, Stakeholder & Buying Criteria - Global Forecast to 2028
The global laboratory proficiency testing market, valued at US$1.1 billion in 2022, stood at US$1.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.4% from 2023 to 2028, culminating in a forecasted valuation of US$1.6 billion by the end of the period. The proficiency testing market is projected to experience substantial expansion in the forecasted period due to its mandatory requirement for laboratories operating in various regulated industries like APIAC, CLIA, and CLSI.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
C – Reactive Protein Testing Market by Assay Type (ELISA, Turbidimetric, Immunoturbidimetric), Application (Cardiovascular, Inflammatory Disease, Rheumatoid Arthritis, Cancer), End User (Hospitals, Clinics, Diagnostics Labs) - Global Forecast to 2023
The Global C-Reactive Protein Testing market is expected to reach USD 1.75 billion by 2023 from USD 1.62 billion in 2018, growing at a CAGR of 1.5 % from 2018 to 2023. Growing occurrences of Non Communicable Diseases (NCDs) such as Cardiovascular Diseases, Diabetes and other inflammatory diseases are the major drivers for this market. Point of Care technology for CRP testing is also being used for diagnostic purposes.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
